Displaying 11 - 20 of 84 for Cancer - All
  • Barrett's Esophagus Study (H-36538)
    • Study of a novel technology, a miniaturized, lower cost microscope device which can be used during upper endoscopy.
  • Biospecimen Banking (H-37203)
    • This study obtains samples from HIV-positive and negative patients with HPV-related cancers of the oropharynx, cervix and anus.
  • BLAST Study (H-36486)
    • The purpose of this study is to compare patient tumor tissue before and after treatment with standard chemotherapy (gemcitabine+cisplatin) plus celecoxib.
  • CareSTEPS Study (H-38998)
    • The purpose of this study to evaluate a program developed for the family caregivers of advanced lung cancer patients.
  • CARPASCIO Study (H-33133)
    • The purpose of this study is to see whether this therapy might help people with lymphoma or leukemia after a stem cell transplantation from a donor.
  • CHARKALL Study (H-23574)
    • Patients have a type of cancer called NHL, Multiple Myeloma (MM) or CLL. The lymphoma, MM or CLL has come back or has not gone away after treatment. This is a gene transfer research study using special immune cells.
  • CHARMS Study (H-33903)
    • Investigators want to see if they can use banked multivirus-specific T cells to treat infections of these viruses after a transplant: Epstein Barr virus (EBV), cytomegalovirus (CMV), BK virus, JC virus, adenovirus or HHV6 (Human Herpes Virus 6).
  • Chemotherapy and Pelvic Radiation Therapy Study (H-37218)
    • Study of chemotherapy and pelvic radiation therapy to see how well they work when given with or without additional chemotherapy in treating patients with high-risk early-stage cervical cancer after radical hysterectomy.
  • Chronic Granulomatous Disease Study (H-14771)
    • The purpose of this research study is to evaluate whether or not patients with CGD treated with a stem cell transplant from a non-matched and/or non-related donor can have a good outcome from the procedure with an acceptable number of side-effects.
  • Cisplatin vs Paclitaxel for Triple Negative Breast Cancer (H-34421)